다계통위축증 소뇌형과 파킨슨형의 부검 소견 비교
Comparison of Neuropathological Characteristics between Multiple System Atrophy Cerebellar Type and Parkinsonian Type
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Multiple system atrophy (MSA) is a sporadic neurodegenerative disease characterized by various combinations of parkinsonism, cerebellar ataxia, autonomic dysfunction and pyramidal signs. Two clinical subtypes are recognized: MSA with predominant cerebellar ataxia (MSA-C) and MSA with predominant parkinsonism (MSA-P). The aim of this study was to compare pathological features between MSA-C and MSA-P. Methods: Two autopsy confirmed cases with MSA were included from the Pusan National University Hospital Brain Bank. Case 1 had been clinically diagnosed as MSA-C and case 2 as MSA-P. The severity of neuronal loss and gliosis as well as the glial and neuronal cytoplasmic inclusions were semiquantitatively assessed in both striatonigral and olivopontocerebellar regions. Based on the grading system, pathological phenotypes of MSA were classified as striatonigral degeneration (SND) predominant (SND type), olivopontocerebellar degeneration (OPC) predominant (OPC type), or equivalent SND and OPC pathology (SND=OPC type). Results: Both cases showed widespread and abundant α-synuclein positive glial cytoplasmic inclusions in association with neurodegenerative changes in striatonigral or olivopontocerebellar structures, leading to the primary pathological diagnosis of MSA. Primary age-related tauopathy was incidentally found but Lewy bodies were not in both cases. The pathological phenotypes of MSA were MSA-OPC type in case 1 and MSA-SND=OPC type in case 2. Conclusions: Our data suggest that clinical phenotypes of MSA reflect the pathological characteristics.
Abstract
Background: Multiple system atrophy (MSA) is a sporadic neurodegenerative disease characterized by various combinations of parkinsonism, cerebellar ataxia, autonomic dysfunction and pyramidal signs. Two clinical subtypes are recognized: MSA with predominant cerebellar ataxia (MSA-C) and MSA with predominant parkinsonism (MSA-P). The aim of this study was to compare pathological features between MSA-C and MSA-P. Methods: Two autopsy confirmed cases with MSA were included from the Pusan National University Hospital Brain Bank. Case 1 had been clinically diagnosed as MSA-C and case 2 as MSA-P. The severity of neuronal loss and gliosis as well as the glial and neuronal cytoplasmic inclusions were semiquantitatively assessed in both striatonigral and olivopontocerebellar regions. Based on the grading system, pathological phenotypes of MSA were classified as striatonigral degeneration (SND) predominant (SND type), olivopontocerebellar degeneration (OPC) predominant (OPC type), or equivalent SND and OPC pathology (SND=OPC type). Results: Both cases showed widespread and abundant α-synuclein positive glial cytoplasmic inclusions in association with neurodegenerative changes in striatonigral or olivopontocerebellar structures, leading to the primary pathological diagnosis of MSA. Primary age-related tauopathy was incidentally found but Lewy bodies were not in both cases. The pathological phenotypes of MSA were MSA-OPC type in case 1 and MSA-SND=OPC type in case 2. Conclusions: Our data suggest that clinical phenotypes of MSA reflect the pathological characteristics.
참고문헌 (19)
- Graham JG, "Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy", J Neurol Neurosurg Psychiatry, 32, pp.28~34 (1969)
- Papp MI, "Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy(striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)", J Neurol Sci, 94, pp.79~100 (1989)
- Gilman S, "Second consensus statement on the diagnosis of multiple system atrophy", Neurology, 71, pp.670~676 (2008)
- Ozawa T, "The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy : clinicopathological correlations", Brain, 127, pp.2657~2671 (2004)
- Ozawa T, "The phenotype spectrum of Japanese multiple system atrophy", J Neurol Neurosurg Psychiatry, 81, pp.1253~1255 (2010)
- Halliday GM, "Neuropathology underlying clinical variability in patients with synucleinopathies", Acta Neuropathol, 122, pp.187~204 (2011)
- 이정환, "다계통위축의 부검증례", 대한신경과학회지, 28(1), pp.56~58 (2010), 대한신경과학회
- Jellinger KA, "Grading of neuropathology in multiple system atrophy : proposal for a novel scale", Mov Disord, 20(Suppl 12), pp.S29~S36 (2005)
- Trojanowski JQ, "Neuropathology Working Group on MSA. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy", Neuropathol Appl Neurobiol, 33, pp.615~620 (2007)
- Jellinger KA, "Multiple system atrophy : an oligodendroglioneural synucleinopathy1", J Alzheimers Dis, 62, pp.1141~1179 (2018)
- Wenning GK, "The natural history of multiple system atrophy : a prospective European cohort study", Lancet Neurol, 12, pp.264~274 (2013)
- Wüllner U, "Definite multiple system atrophy in a German family", J Neurol Neurosurg Psychiatry, 80, pp.449~450 (2009)
- Wakabayashi K, "An autopsy case of early("minimal change")olivopontocerebellar atrophy(multiple system atrophy-cerebellar)", Acta Neuropathol, 110, pp.185~190 (2005)
- Wenning GK, "The role of alpha-synuclein in the pathogenesis of multiple system atrophy", Acta Neuropathol, 109, pp.129~140 (2005)
- Koga S, "Profile of cognitive impairment and underlying pathology in multiple system atrophy", Mov Disord, 32, pp.405~413 (2017)
- Koga S, "Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy", J Neurol Neurosurg Psychiatry, 89, pp.175~184 (2018)
- Yabe I, "MSA-C is the predominant clinical phenotype of MSA in Japan : analysis of 142patients with probable MSA", J Neurol Sci, 249, pp.115~121 (2006)
- Gilman S, "The North American Multiple System Atrophy Study Group", J Neural Transm(Vienna), 112, pp.1687~1694 (2005)
- Watanabe H, "Progression and prognosis in multiple system atrophy : an analysis of 230 Japanese patients", Brain, 125, pp.1070~1083 (2002)